Real-time stock and forex trading analysis, featuring market trends, price fluctuations, and actionable trading ideas. With detailed charts and expert insights, it helps users make informed decisions in a streamlined, user-friendly interface.

Wednesday, July 26, 2017

The Strange Case of Martin Shkreli Is Wrapping Up

July 26, 2017 0 comments
In February 2013, Martin Shkreli was contemplating a deal that involved acquiring shares of Retrophin, the pharmaceutical company he ran, at below the market price. His lawyer advised him to be careful, writing: “Not the best course of action - you are the director and ceo of a public company, yo...

The Strange Case of Martin Shkreli Is Wrapping Up
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)